MedTrace Logo

Trial to Evaluate the Efficacy and Safety of HCP1302

NCT02587988 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 232

Last updated 2016-11-01

No results posted yet for this study

Summary

Trial to Evaluate the Efficacy and Safety of HCP1302

Conditions

Interventions

DRUG

HCP1302

DRUG

HGP0904

DRUG

Placebo (for HCP1302)

DRUG

Placebo (for HGP0904)

Sponsors & Collaborators

  • Hanmi Pharmaceutical Company Limited

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-05-31
Completion
2015-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02587988 on ClinicalTrials.gov